Abstract
Objective
There remains significant variation in the level and rate of adoption of new pediatric respiratory technologies, in spite of two decades of focus on “evidence-based medicine”. Nearly 50 years ago Rogers introduced a rubric for understanding issues that effect the adoption of technologies that included four factors plus evidence of advantage. We sought to determine whether Rogers' factors were useful in understanding contrasts between clinical utilization of technology and evidence of advantage.
Design, setting, participants
We conducted a written survey at two international neonatal/pediatric respiratory conferences. We asked about use of four specific indications for high-frequency ventilation (HFV) and nasal continuous positive airway pressure (nCPAP).
Results
These four specific respiratory therapies were aggressively used by most, despite significant differences in the evidence supporting their utility: elective use of HFV (57.4%); HFV to treat ARDS (62.7%); nCPAP for weaning following extubation (83.9%); and nCPAP to avoid intubation (82.1%).
Conclusions
Evidence of outcomes advantage should be the key factor in assessing potentially beneficial technologies. However, we suggest that understanding the influence of observe-ability, complexity and subjectivity of relative advantage explains much of the contrast between adoption level and outcome evidence. These factors described by Rogers, that encourage adoption of mediocre technologies or that retard adoption of potentially beneficial technologies, should be understood and acknowledged. This perspective can be applied not only to national adoption patterns, but also to adoption of best practices within an individual unit.
References
Horbar JD, Badger GJ, Lewit EM, Rogowski J, Shiono PH (1997) Hospital and patient characteristics associated with variation in 28-day mortality rates for very low birth weigh infants. Pediatrics 99:149–155
Soll RF, Andruscavage L (1999) The principles and practice of evidence-based neonatology. Pediatrics 103:215–224
Horbar JD (1999) The Vermont–Oxford Network: evidence-based quality improvement for neonatology. Pediatrics 103:350–359
Rogers EM (1962) Diffusion of innovations. Free Press, New York
Haider M, Kreps GL (2004) Forty years of diffusion of innovation: utility and value in public health. J Health Commun 9(Suppl 1):3–11
Horbar JD, Badger GJ, Carpenter JH, Fanaroff AA, Kilpatrick S, LaCorte M, Phibbs R, Soll RF, Members of the Vermont Oxford Network (2002) Trends in mortality and morbidity for very low birth weight infants, 1991–1999. Pediatrics 110:143–151
Davis PG, Henderson-Smart DJ (2003) Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev 2:CD000143
Henderson-Smart DJ, Bhuta T, Cools F, Offringa M (2003) Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev 4:CD000104
Arnold JH, Hanson JH, Toro-Figuero LO, Gutierrez J, Berens RJ, Anglin DL (1994) Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med 22:1530–1539
Subramaniam P, Henderson-Smart DJ, Davis PG (2005) Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in very preterm infants. Cochrane Database Syst Rev 3:CD001243
Bhuta T, Clark RH, Henderson-Smart DJ (2001) Rescue high frequency oscillatory ventilation vs. conventional ventilation for infants with severe pulmonary dysfunction born at or near term. Cochrane Database Syst Rev 1:CD002974
Bhuta T, Henderson-Smart DJ (2001) Rescue high frequency oscillatory ventilation versus conventional ventilation for pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev 3:CD000104
Courtney SE, Durand DJ, Asselin JM, Hudak ML, Aschner JL, Shoemaker CT, Neonatal Ventilation Study Group (2002) High frequency oscillatory ventilation versus conventional mechanical ventilation for very low birth weight infants. N Engl J Med 347:643–652
Moriette G, Paris-Llado J, Walti H, Escande B, Magny JF, Cambonie G, Thiriez G, Cantagrel S, Lacaze-Masmonteil T, Storme L, Blanc T, Liet JM, Andre C, Salanave B, Breart G (2001) Prospective randomized multicenter comparison of high frequency oscillatory ventilation and conventional ventilation in preterm infants < 30 weeks gestational age with RDS. Pediatrics 107:363–372
Johnson AH, Peacock JL, Greenough A, Marlow N, Limb ES, Marston L, Calvert SA, United Kingdom Oscillation Study Group (2002) High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity. N Engl J Med 347:633–642
Keszler M (2006) High-frequency ventilation: evidence-based practice and specific clinical indications. NeoReviews 7:234–249
Anonymous (1993) Randomized study of high-frequency oscillatory ventilation in infants with severe respiratory distress syndrome. HiFO Study Group. J Pediatr 122:609–619
Clark RH, Yoder BA, Sell MS (1994) Prospective randomized comparison of high-frequency oscillatory and conventional ventilation in candidates for extracorporeal membrane oxygenation. J Pediatr 124:447–454
Arnold JH, Anas NG, Luckett P, Cheifetz IM, Reyes G, Newth CJL, Kocis KC, Heidemann SM, Hanson JH, Brogan TV, Bohn DJ (2000) High frequency oscillatory ventilation in pediatric respiratory failure: a multicenter experience. Crit Care Med 28:3913–3919
Thome UH, Carlo WA, Pohlandt F (2005) Ventilation strategies and outcome in randomised trials of high frequency ventilation. Arch Dis Child Fetal Neonatal Ed 90:F466–473
Kaam AH, Rimensberger PC (2007) Lung protective strategies in neonatology: What do we know—what do we need to know? Crit Care Med 35:925–931
Sharek PJ, Baker R, Litman F, Kaempf J, Burch K, Schwarz E, Sun S, Payne NR (2003) Evaluation and development of potentially better practices to prevent chronic lung disease and reduce lung injury in neonates. Pediatrics 111:426–421
Bollen CW, Ulterwaal CSPM, vanVught AJ (2007) Meta-regression analysis of high-frequency ventilation vs. conventional ventilation in infant respiratory distress syndrome. Intensive Care Med 33:680–688
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Key questions
Key questions
“When new clinical concepts are emerging personal interest,” ranging across the five-point Likert scale from “eager to use” to “no interest”. “Use of HFV for VLBW infants,” ranging across the five-point Likert scale from “first intention” to “only rescue”. “Use of HFV for pediatric and term infants with ARDS,” ranging across the five-point Likert scale from “early” to “last choice for rescue”. “Use of nCPAP to prevent the need for mechanical ventilation,” ranging across the five-point Likert scale from “always” to “never”. “Use of nCPAP to prevent the need for mechanical ventilation,” ranging across the five-point Likert scale from “always” to “never”.
Rights and permissions
About this article
Cite this article
Bachman, T.E., Marks, N.E. & Rimensberger, P.C. Factors effecting adoption of new neonatal and pediatric respiratory technologies. Intensive Care Med 34, 174–178 (2008). https://doi.org/10.1007/s00134-007-0914-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-007-0914-6